Literature DB >> 9596579

Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.

M Camps1, A Nichols, C Gillieron, B Antonsson, M Muda, C Chabert, U Boschert, S Arkinstall.   

Abstract

MAP kinase phosphatase-3 (MKP-3) dephosphorylates phosphotyrosine and phosphothreonine and inactivates selectively ERK family mitogen-activated protein (MAP) kinases. MKP-3 was activated by direct binding to purified ERK2. Activation was independent of protein kinase activity and required binding of ERK2 to the noncatalytic amino-terminus of MKP-3. Neither the gain-of-function Sevenmaker ERK2 mutant D319N nor c-Jun amino-terminal kinase-stress-activated protein kinase (JNK/SAPK) or p38 MAP kinases bound MKP-3 or caused its catalytic activation. These kinases were also resistant to enzymatic inactivation by MKP-3. Another homologous but nonselective phosphatase, MKP-4, bound and was activated by ERK2, JNK/SAPK, and p38 MAP kinases. Catalytic activation of MAP kinase phosphatases through substrate binding may regulate MAP kinase activation by a large number of receptor systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596579     DOI: 10.1126/science.280.5367.1262

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  144 in total

1.  Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.

Authors:  D Y Choi; J J Toledo-Aral; R Segal; S Halegoua
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Increased protein kinase or decreased PP2A activity bypasses sphingoid base requirement in endocytosis.

Authors:  S Friant; B Zanolari; H Riezman
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 3.  Paradoxical signal transduction in neurobiological systems.

Authors:  F C Colpaert; Y Frégnac
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

Review 4.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

6.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

Review 7.  Signal control through Raf: in sickness and in health.

Authors:  Jihan K Osborne; Elma Zaganjor; Melanie H Cobb
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

8.  Different mechanisms account for extracellular-signal regulated kinase activation in distinct brain regions following global ischemia and reperfusion.

Authors:  Y Ho; E Logue; C W Callaway; D B DeFranco
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

9.  Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.

Authors:  Andreas Vogt; John S Lazo
Journal:  Methods       Date:  2007-07       Impact factor: 3.608

10.  The C.elegans MAPK phosphatase LIP-1 is required for the G(2)/M meiotic arrest of developing oocytes.

Authors:  Alex Hajnal; Thomas Berset
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.